Literature DB >> 16105736

Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.

Alireza Foroumadi1, Saeed Emami, Abdolreza Hassanzadeh, Majid Rajaee, Kazem Sokhanvar, Mohammad Hassan Moshafi, Abbas Shafiee.   

Abstract

A series of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl) derivatives of piperazinyl quinolones was synthesized and evaluated for antibacterial activity against Gram-positive and Gram-negative microorganisms. Some of these derivatives exhibit high activity against Gram-positive bacteria; Staphylococcus aureus and Staphylococcus epidermidis, comparable or more potent than their parent N-piperazinyl quinolones norfloxacin and ciprofloxacin as reference drugs. The SAR of this series indicates that both the structure of the benzyl unit and the S or SO(2) linker dramatically impact antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105736     DOI: 10.1016/j.bmcl.2005.07.016

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  New 7-piperazinylquinolones containing (benzo[d]imidazol-2-yl)methyl moiety as potent antibacterial agents.

Authors:  Hojat-Allah Arab; Mohammad Ali Faramarzi; Nasrin Samadi; Hamid Irannejad; Alireza Foroumadi; Saeed Emami
Journal:  Mol Divers       Date:  2018-06-07       Impact factor: 2.943

2.  Synthesis and Antimicrobial Activity Screening of Piperazines Bearing N,N'-Bis(1,3,4-thiadiazole) Moiety as Probable Enoyl-ACP Reductase Inhibitors.

Authors:  Alaa Z Omar; Najla A Alshaye; Tawfik M Mosa; Samir K El-Sadany; Ezzat A Hamed; Mohamed A El-Atawy
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

3.  Synthesis and Biological Screening of 5-{[(4,6-Disubstituted pyrimidine-2-yl)thio]methyl}-N-phenyl-1,3,4-thiadiazol-2-amines.

Authors:  M A Azam; B R P Kumar; S Shalini; B Suresh; T K Reddy; C D Reddy
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

4.  Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones.

Authors:  Anna Bielenica; Jerzy Kossakowski; Marta Struga; Izabela Dybała; Roberta Loddo; Cristina Ibba; Paolo La Colla
Journal:  Sci Pharm       Date:  2011-02-12

Review 5.  Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles.

Authors:  Bhawna Sharma; Amita Verma; Sunil Prajapati; Upendra Kumar Sharma
Journal:  Int J Med Chem       Date:  2013-04-30

6.  Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.

Authors:  Zhi Xu; Shu Zhang; Lian-Shun Feng; Xiao-Ning Li; Guo-Cheng Huang; Yun Chai; Zao-Sheng Lv; Hui-Yuan Guo; Ming-Liang Liu
Journal:  Molecules       Date:  2017-07-13       Impact factor: 4.411

7.  4-Azatricyclo[5.2.2.02,6]undecane-3,5,8-triones as potential pharmacological agents.

Authors:  Jerzy Kossakowski; Anna Bielenica; Barbara Mirosław; Anna E Kozioł; Izabela Dybała; Marta Struga
Journal:  Molecules       Date:  2008-08-06       Impact factor: 4.411

8.  Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids.

Authors:  Tomasz Plech; Barbara Kaproń; Agata Paneth; Urszula Kosikowska; Anna Malm; Aleksandra Strzelczyk; Paweł Stączek; Łukasz Świątek; Barbara Rajtar; Małgorzata Polz-Dacewicz
Journal:  Molecules       Date:  2015-04-09       Impact factor: 4.411

9.  Ciprofloxacin-Tethered 1,2,3-Triazole Conjugates: New Quinolone Family Compounds to Upgrade Our Antiquated Approach against Bacterial Infections.

Authors:  Alka Agarwal; Preeti Singh; Anand Maurya; Upendra Kumar Patel; Alka Singh; Gopal Nath
Journal:  ACS Omega       Date:  2022-01-11

10.  Synthesis, Antibacterial Evaluation and QSAR of α-Substituted-N₄-Acetamides of Ciprofloxacin and Norfloxacin.

Authors:  Amjad M Qandil; Lorca O Al-Zoubi; Amal G Al-Bakri; Haneen A Amawi; Qosay A Al-Balas; Abdulmalik M Alkatheri; Abdulkareem M Albekairy
Journal:  Antibiotics (Basel)       Date:  2014-06-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.